United States Phosphodiesterase Inhibitor Market Report 2016

Publisher Name :
Date: 15-Sep-2016
No. of pages: 122
Inquire Before Buying

Notes:

Sales, means the sales volume of Phosphodiesterase Inhibitor

Revenue, means the sales value of Phosphodiesterase Inhibitor

This report studies sales (consumption) of Phosphodiesterase Inhibitor in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering

- Actelion Pharmaceuticals Ltd.

- United Therapeutics Corporation

- Gilead sciences

- Bayer AG

- SteadyMed Ltd.

- GlaxoSmithKline plc

- Pfizer Inc.

- Reata Pharmaceuticals Inc.

- Arena Pharmaceuticals Inc.

- Merck & Co. Inc

Split by product Types, with sales, revenue, price, market share and growth rate of each type, can be divided into

- Type I

- Type II

- Type III

Split by applications, this report focuses on sales, market share and growth rate of Phosphodiesterase Inhibitor in each application, can be divided into

- Health care

- Clinic

- Hospital

United States Phosphodiesterase Inhibitor Market Report 2016

Table of Contents
United States Phosphodiesterase Inhibitor Market Report 2016
1 Phosphodiesterase Inhibitor Overview
1.1 Product Overview and Scope of Phosphodiesterase Inhibitor
1.2 Classification of Phosphodiesterase Inhibitor
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Phosphodiesterase Inhibitor
1.3.1 Health care
1.3.2 Clinic
1.3.3 Hospital
1.4 USA Market Size Sales (Value) and Revenue (Volume) of Phosphodiesterase Inhibitor (2011-2021)
1.4.1 USA Phosphodiesterase Inhibitor Sales and Growth Rate (2011-2021)
1.4.2 USA Phosphodiesterase Inhibitor Revenue and Growth Rate (2011-2021)
2 USA Phosphodiesterase Inhibitor Competition by Manufacturers
2.1 USA Phosphodiesterase Inhibitor Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 USA Phosphodiesterase Inhibitor Revenue and Share by Manufactures (2015 and 2016)
2.3 USA Phosphodiesterase Inhibitor Average Price by Manufactures (2015 and 2016)
2.4 Phosphodiesterase Inhibitor Market Competitive Situation and Trends
2.4.1 Phosphodiesterase Inhibitor Market Concentration Rate
2.4.2 Phosphodiesterase Inhibitor Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 USA Phosphodiesterase Inhibitor Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 USA Phosphodiesterase Inhibitor Sales and Market Share by Type (2011-2016)
3.2 USA Phosphodiesterase Inhibitor Revenue and Market Share by Type (2011-2016)
3.3 USA Phosphodiesterase Inhibitor Price by Type (2011-2016)
3.4 USA Phosphodiesterase Inhibitor Sales Growth Rate by Type (2011-2016)
4 USA Phosphodiesterase Inhibitor Sales (Volume) by Application (2011-2016)
4.1 USA Phosphodiesterase Inhibitor Sales and Market Share by Application (2011-2016)
4.2 USA Phosphodiesterase Inhibitor Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities
5 USA Phosphodiesterase Inhibitor Manufacturers Profiles/Analysis
5.1 Actelion Pharmaceuticals Ltd.
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Phosphodiesterase Inhibitor Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 Actelion Pharmaceuticals Ltd. Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 United Therapeutics Corporation
5.2.2 Phosphodiesterase Inhibitor Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 United Therapeutics Corporation Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 Gilead sciences
5.3.2 Phosphodiesterase Inhibitor Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 Gilead sciences Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 Bayer AG
5.4.2 Phosphodiesterase Inhibitor Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 Bayer AG Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
5.5 SteadyMed Ltd.
5.5.2 Phosphodiesterase Inhibitor Product Type, Application and Specification
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 SteadyMed Ltd. Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
5.5.4 Main Business/Business Overview
5.6 GlaxoSmithKline plc
5.6.2 Phosphodiesterase Inhibitor Product Type, Application and Specification
5.6.2.1 Type I
5.6.2.2 Type II
5.6.3 GlaxoSmithKline plc Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
5.6.4 Main Business/Business Overview
5.7 Pfizer Inc.
5.7.2 Phosphodiesterase Inhibitor Product Type, Application and Specification
5.7.2.1 Type I
5.7.2.2 Type II
5.7.3 Pfizer Inc. Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
5.7.4 Main Business/Business Overview
5.8 Reata Pharmaceuticals Inc.
5.8.2 Phosphodiesterase Inhibitor Product Type, Application and Specification
5.8.2.1 Type I
5.8.2.2 Type II
5.8.3 Reata Pharmaceuticals Inc. Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
5.8.4 Main Business/Business Overview
5.9 Arena Pharmaceuticals Inc.
5.9.2 Phosphodiesterase Inhibitor Product Type, Application and Specification
5.9.2.1 Type I
5.9.2.2 Type II
5.9.3 Arena Pharmaceuticals Inc. Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
5.9.4 Main Business/Business Overview
5.10 Merck & Co. Inc
5.10.2 Phosphodiesterase Inhibitor Product Type, Application and Specification
5.10.2.1 Type I
5.10.2.2 Type II
5.10.3 Merck & Co. Inc Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
5.10.4 Main Business/Business Overview
6 Phosphodiesterase Inhibitor Manufacturing Cost Analysis
6.1 Phosphodiesterase Inhibitor Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Phosphodiesterase Inhibitor
7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Phosphodiesterase Inhibitor Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Phosphodiesterase Inhibitor Major Manufacturers in 2015
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List
9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change
10 USA Phosphodiesterase Inhibitor Market Forecast (2016-2021)
10.1 USA Phosphodiesterase Inhibitor Sales, Revenue Forecast (2016-2021)
10.2 USA Phosphodiesterase Inhibitor Sales Forecast by Type (2016-2021)
10.3 USA Phosphodiesterase Inhibitor Sales Forecast by Application (2016-2021)
10.4 Phosphodiesterase Inhibitor Price Forecast (2016-2021)
11 Research Findings and Conclusion
12 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
List of Tables and Figures
Figure Picture of Phosphodiesterase Inhibitor
Table Classification of Phosphodiesterase Inhibitor
Figure USA Sales Market Share of Phosphodiesterase Inhibitor by Type in 2015
Table Application of Phosphodiesterase Inhibitor
Figure USA Sales Market Share of Phosphodiesterase Inhibitor by Application in 2015
Figure Health care Examples
Figure Clinic Examples
Figure Hospital Examples
Figure USA Phosphodiesterase Inhibitor Sales and Growth Rate (2011-2021)
Figure USA Phosphodiesterase Inhibitor Revenue and Growth Rate (2011-2021)
Table USA Phosphodiesterase Inhibitor Sales of Key Manufacturers (2015 and 2016)
Table USA Phosphodiesterase Inhibitor Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Phosphodiesterase Inhibitor Sales Share by Manufacturers
Figure 2016 Phosphodiesterase Inhibitor Sales Share by Manufacturers
Table USA Phosphodiesterase Inhibitor Revenue by Manufacturers (2015 and 2016)
Table USA Phosphodiesterase Inhibitor Revenue Share by Manufacturers (2015 and 2016)
Table 2015 USA Phosphodiesterase Inhibitor Revenue Share by Manufacturers
Table 2016 USA Phosphodiesterase Inhibitor Revenue Share by Manufacturers
Table USA Market Phosphodiesterase Inhibitor Average Price of Key Manufacturers (2015 and 2016)
Figure USA Market Phosphodiesterase Inhibitor Average Price of Key Manufacturers in 2015
Figure Phosphodiesterase Inhibitor Market Share of Top 3 Manufacturers
Figure Phosphodiesterase Inhibitor Market Share of Top 5 Manufacturers
Table USA Phosphodiesterase Inhibitor Sales by Type (2011-2016)
Table USA Phosphodiesterase Inhibitor Sales Share by Type (2011-2016)
Figure USA Phosphodiesterase Inhibitor Sales Market Share by Type in 2015
Table USA Phosphodiesterase Inhibitor Revenue and Market Share by Type (2011-2016)
Table USA Phosphodiesterase Inhibitor Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Phosphodiesterase Inhibitor by Type (2011-2016)
Table USA Phosphodiesterase Inhibitor Price by Type (2011-2016)
Figure USA Phosphodiesterase Inhibitor Sales Growth Rate by Type (2011-2016)
Table USA Phosphodiesterase Inhibitor Sales by Application (2011-2016)
Table USA Phosphodiesterase Inhibitor Sales Market Share by Application (2011-2016)
Figure USA Phosphodiesterase Inhibitor Sales Market Share by Application in 2015
Table USA Phosphodiesterase Inhibitor Sales Growth Rate by Application (2011-2016)
Figure USA Phosphodiesterase Inhibitor Sales Growth Rate by Application (2011-2016)
Table Actelion Pharmaceuticals Ltd. Basic Information List
Table Actelion Pharmaceuticals Ltd. Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Actelion Pharmaceuticals Ltd. Phosphodiesterase Inhibitor Sales Market Share (2011-2016)
Table United Therapeutics Corporation Basic Information List
Table United Therapeutics Corporation Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
Table United Therapeutics Corporation Phosphodiesterase Inhibitor Sales Market Share (2011-2016)
Table Gilead sciences Basic Information List
Table Gilead sciences Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
Table Gilead sciences Phosphodiesterase Inhibitor Sales Market Share (2011-2016)
Table Bayer AG Basic Information List
Table Bayer AG Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer AG Phosphodiesterase Inhibitor Sales Market Share (2011-2016)
Table SteadyMed Ltd. Basic Information List
Table SteadyMed Ltd. Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
Table SteadyMed Ltd. Phosphodiesterase Inhibitor Sales Market Share (2011-2016)
Table GlaxoSmithKline plc Basic Information List
Table GlaxoSmithKline plc Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline plc Phosphodiesterase Inhibitor Sales Market Share (2011-2016)
Table Pfizer Inc. Basic Information List
Table Pfizer Inc. Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Inc. Phosphodiesterase Inhibitor Sales Market Share (2011-2016)
Table Reata Pharmaceuticals Inc. Basic Information List
Table Reata Pharmaceuticals Inc. Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
Table Reata Pharmaceuticals Inc. Phosphodiesterase Inhibitor Sales Market Share (2011-2016)
Table Arena Pharmaceuticals Inc. Basic Information List
Table Arena Pharmaceuticals Inc. Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
Table Arena Pharmaceuticals Inc. Phosphodiesterase Inhibitor Sales Market Share (2011-2016)
Table Merck & Co. Inc Basic Information List
Table Merck & Co. Inc Phosphodiesterase Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck & Co. Inc Phosphodiesterase Inhibitor Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Phosphodiesterase Inhibitor
Figure Manufacturing Process Analysis of Phosphodiesterase Inhibitor
Figure Phosphodiesterase Inhibitor Industrial Chain Analysis
Table Raw Materials Sources of Phosphodiesterase Inhibitor Major Manufacturers in 2015
Table Major Buyers of Phosphodiesterase Inhibitor
Table Distributors/Traders List
Figure USA Phosphodiesterase Inhibitor Production and Growth Rate Forecast (2016-2021)
Figure USA Phosphodiesterase Inhibitor Revenue and Growth Rate Forecast (2016-2021)
Table USA Phosphodiesterase Inhibitor Production Forecast by Type (2016-2021)
Table USA Phosphodiesterase Inhibitor Consumption Forecast by Application (2016-2021)
  • China Transcatheter Mitral Valve Repair and Replacement Market Research Report 2018
    Published: 24-Apr-2018        Price: US 3400 Onwards        Pages: 102
    The global Transcatheter Mitral Valve Repair and Replacement market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. China plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of xx%. This report studies the Transcatheter Mitral Valve Repair and Replacement development status and future trend i......
  • China Tissue Engineered Bone Market Research Report 2018
    Published: 24-Apr-2018        Price: US 3400 Onwards        Pages: 101
    The global Tissue Engineered Bone market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. China plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of xx%. This report studies the Tissue Engineered Bone development status and future trend in China, focuses on top players in China, also splits ......
  • China Theobroma Oil Market Research Report 2018
    Published: 24-Apr-2018        Price: US 3400 Onwards        Pages: 104
    The global Theobroma Oil market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. China plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of xx%. This report studies the Theobroma Oil development status and future trend in China, focuses on top players in China, also splits Theobroma Oil by t......
  • China Superoxide Dismutase [Cu-Zn] Market Research Report 2018
    Published: 24-Apr-2018        Price: US 3400 Onwards        Pages: 97
    The global Superoxide Dismutase [Cu-Zn] market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. China plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of xx%. This report studies the Superoxide Dismutase [Cu-Zn] development status and future trend in China, focuses on top players in China, ......
  • China Receptor Tyrosine Protein Kinase ERBB 4 Market Research Report 2018
    Published: 24-Apr-2018        Price: US 3400 Onwards        Pages: 113
    The global Receptor Tyrosine Protein Kinase ERBB 4 market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. China plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of xx%. This report studies the Receptor Tyrosine Protein Kinase ERBB 4 development status and future trend in China, focuses on ......
  • China RAF Proto Oncogene Serine/Threonine Protein Kinase Market Research Report 2018
    Published: 24-Apr-2018        Price: US 3400 Onwards        Pages: 100
    The global RAF Proto Oncogene Serine/Threonine Protein Kinase market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. China plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of xx%. This report studies the RAF Proto Oncogene Serine/Threonine Protein Kinase development status and future trend......
  • China Radix Isatidis Market Research Report 2018
    Published: 24-Apr-2018        Price: US 3400 Onwards        Pages: 100
    The global Radix Isatidis market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. China plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of xx%. This report studies the Radix Isatidis development status and future trend in China, focuses on top players in China, also splits Radix Isatidis b......
  • China Protein Kinase C Epsilon Type Market Research Report 2018
    Published: 24-Apr-2018        Price: US 3400 Onwards        Pages: 96
    The global Protein Kinase C Epsilon Type market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. China plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of xx%. This report studies the Protein Kinase C Epsilon Type development status and future trend in China, focuses on top players in China......
  • China Proprotein Convertase Subtilisin/Kexin Type 9 Market Research Report 2018
    Published: 24-Apr-2018        Price: US 3400 Onwards        Pages: 113
    The global Proprotein Convertase Subtilisin/Kexin Type 9 market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. China plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of xx%. This report studies the Proprotein Convertase Subtilisin/Kexin Type 9 development status and future trend in China,......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs